Cromos™ Pharma is a premier regional CRO with operations in Central and Eastern Europe, former Soviet republics and Israel
Cromos Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical outsourcing to Georgia, Belarus, Russia, Ukraine, countries of Eastern Europe, Israel and Baltic states – areas with very compelling environment for biopharmaceutical research. The company manages Phase I-IV clinical trials, bioequivalence and observational studies and has been successfully operating since 2004.
Our business model is a product of the most validated Western solutions which are carefully tailored to local environments.
Full compliance with ICH GCP regulations, motivated and experienced investigators with impeccable reputations, large patient population is the integral to our ability to provide high quality and affordable services.
As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos Pharma you get an invariable guarantee that your project will be handled by the "A-team".
In 2012 Cromos Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead.
Cromos Pharma offers budget-friendly clinical outsourcing solutions via innovative operational structure and project-specific alliances. We guarantee speed, quality, and best experts in the field. Our intricate knowledge of the market, long-term working relationship and personal ties with the best research centers and health care authorities translate into a unique capability to accomplish the most difficult tasks.
Please, contact us to learn more about Cromos Pharma clinical trial services.
clinical trials in Baltic states and Lithuania
Clinical monitoring in Eastern Europe – Administrative and Oversight efforts that monitor a participant's health during a clinical trial. Clinical trial funding agencies and government in Estonia and Russia require safety monitoring boards and data to oversee clinical trials.
Cromos™ Pharma at New York CEO Conference / 07.10.2014
Cromos™ Pharma CEO, Dr. Bogin, will be presenting at MAGI Clinical Research Conference that takes place in San Francisco on November 9-12, 2014 / 07.10.2014
Cromos Pharma conducted the webinar “SWOT analysis of clinical trials in post-Soviet countries” / 31.07.2014
Cromos Pharma published white paper that discusses strategic vs. transactional partnership structure between Pharma and CROs / 26.06.2014